(Q41637628)

English

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program

scientific article published on November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

object named as

Alyssa M Cornall

4

0 references

Yasmin Jayasinghe

object named as

Yasmin Jayasinghe

7

0 references

Sepehr N Tabrizi

2

object named as

Sepehr N Tabrizi

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Suzanne Marie Garland

10

object named as

Suzanne M Garland

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Dorota M. Gertig

8

object named as

Dorota M Gertig

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

author name string

Sarah L Osborne

1

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Julia M L Brotherton

3

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

John D Wark

5

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

C David Wrede

6

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Marian K Pitts

9

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

VACCINE Study group

11

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

language of work or name

0 references

publication date

1 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

201-208

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Molecular biology of human papillomavirus infection and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Chapter 5: Updating the natural history of HPV and anogenital cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Web-based recruiting for health research using a social networking site: an exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Human papillomavirus genotyping using a modified linear array detection protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Diagnosis of sexually transmitted infections (STI) using self-collected non-invasive specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Women's Health Australia: On the Progress of the Main Cohort Studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.10.045

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41637628&oldid=2179701971"